

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.66526099 |
| 2 | proteasome assembly (GO:0043248) | 5.42936027 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.26596172 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.26596172 |
| 5 | cullin deneddylation (GO:0010388) | 4.94381949 |
| 6 | protein deneddylation (GO:0000338) | 4.68097998 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.61044625 |
| 8 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.48874655 |
| 9 | termination of RNA polymerase III transcription (GO:0006386) | 4.42651720 |
| 10 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.42651720 |
| 11 | chaperone-mediated protein transport (GO:0072321) | 4.40496722 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.38456567 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 4.38456567 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.38456567 |
| 15 | protein neddylation (GO:0045116) | 4.37726814 |
| 16 | protein complex biogenesis (GO:0070271) | 4.28455951 |
| 17 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.27280424 |
| 18 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.18378295 |
| 19 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.14276820 |
| 20 | ribosomal small subunit biogenesis (GO:0042274) | 4.09605408 |
| 21 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.08461373 |
| 22 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.07733326 |
| 23 | * negative regulation of ligase activity (GO:0051352) | 4.07733326 |
| 24 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.05727054 |
| 25 | ribosome assembly (GO:0042255) | 4.04773031 |
| 26 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.03080871 |
| 27 | DNA deamination (GO:0045006) | 4.02800546 |
| 28 | 7-methylguanosine mRNA capping (GO:0006370) | 4.02125996 |
| 29 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.00518741 |
| 30 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.00518741 |
| 31 | RNA capping (GO:0036260) | 3.99941231 |
| 32 | 7-methylguanosine RNA capping (GO:0009452) | 3.99941231 |
| 33 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.98591505 |
| 34 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.98591505 |
| 35 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.98591505 |
| 36 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.96356172 |
| 37 | DNA replication checkpoint (GO:0000076) | 3.90638386 |
| 38 | respiratory electron transport chain (GO:0022904) | 3.89203239 |
| 39 | DNA double-strand break processing (GO:0000729) | 3.87129029 |
| 40 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.85140346 |
| 41 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.82063079 |
| 42 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.82063079 |
| 43 | maturation of SSU-rRNA (GO:0030490) | 3.81261090 |
| 44 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.80869479 |
| 45 | electron transport chain (GO:0022900) | 3.78772947 |
| 46 | histone exchange (GO:0043486) | 3.77795933 |
| 47 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.77211116 |
| 48 | mitotic metaphase plate congression (GO:0007080) | 3.77046626 |
| 49 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.75741893 |
| 50 | respiratory chain complex IV assembly (GO:0008535) | 3.68097723 |
| 51 | cotranslational protein targeting to membrane (GO:0006613) | 3.66347171 |
| 52 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.66306658 |
| 53 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.65720695 |
| 54 | GTP biosynthetic process (GO:0006183) | 3.65593726 |
| 55 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.63956508 |
| 56 | establishment of integrated proviral latency (GO:0075713) | 3.63045258 |
| 57 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.62353527 |
| 58 | protein targeting to ER (GO:0045047) | 3.57924368 |
| 59 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.57791225 |
| 60 | viral mRNA export from host cell nucleus (GO:0046784) | 3.57158058 |
| 61 | viral transcription (GO:0019083) | 3.56442622 |
| 62 | ribosomal large subunit biogenesis (GO:0042273) | 3.55910637 |
| 63 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.53543799 |
| 64 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.53543799 |
| 65 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.52919943 |
| 66 | translational termination (GO:0006415) | 3.52006907 |
| 67 | IMP biosynthetic process (GO:0006188) | 3.51987523 |
| 68 | regulation of mitochondrial translation (GO:0070129) | 3.51251878 |
| 69 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.49985235 |
| 70 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.49985235 |
| 71 | protein localization to endoplasmic reticulum (GO:0070972) | 3.48890147 |
| 72 | translation (GO:0006412) | 3.48527042 |
| 73 | DNA replication-independent nucleosome organization (GO:0034724) | 3.46780352 |
| 74 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.46780352 |
| 75 | DNA strand elongation (GO:0022616) | 3.45495431 |
| 76 | * positive regulation of ligase activity (GO:0051351) | 3.44072860 |
| 77 | histone mRNA metabolic process (GO:0008334) | 3.41286523 |
| 78 | metaphase plate congression (GO:0051310) | 3.40556028 |
| 79 | protein targeting to mitochondrion (GO:0006626) | 3.38998411 |
| 80 | * regulation of ligase activity (GO:0051340) | 3.38927131 |
| 81 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.38766344 |
| 82 | CENP-A containing nucleosome assembly (GO:0034080) | 3.37926752 |
| 83 | DNA damage response, detection of DNA damage (GO:0042769) | 3.36210091 |
| 84 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.36023238 |
| 85 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.34791834 |
| 86 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.34791834 |
| 87 | spliceosomal snRNP assembly (GO:0000387) | 3.34250498 |
| 88 | cytochrome complex assembly (GO:0017004) | 3.33978289 |
| 89 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.33765786 |
| 90 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.33261398 |
| 91 | pseudouridine synthesis (GO:0001522) | 3.31360952 |
| 92 | establishment of protein localization to mitochondrion (GO:0072655) | 3.30981552 |
| 93 | rRNA modification (GO:0000154) | 3.30356788 |
| 94 | cellular component biogenesis (GO:0044085) | 3.28155920 |
| 95 | regulation of helicase activity (GO:0051095) | 3.28079640 |
| 96 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.28052578 |
| 97 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.26646190 |
| 98 | establishment of viral latency (GO:0019043) | 3.26200842 |
| 99 | purine nucleobase biosynthetic process (GO:0009113) | 3.25794394 |
| 100 | oxidative phosphorylation (GO:0006119) | 3.25217435 |
| 101 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.24641453 |
| 102 | DNA ligation (GO:0006266) | 3.24301154 |
| 103 | * regulation of cellular amine metabolic process (GO:0033238) | 3.22283475 |
| 104 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.21914017 |
| 105 | * negative regulation of protein ubiquitination (GO:0031397) | 3.21409050 |
| 106 | spindle checkpoint (GO:0031577) | 3.20695825 |
| 107 | kinetochore organization (GO:0051383) | 3.20677279 |
| 108 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.20002945 |
| 109 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.20002945 |
| 110 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.20002945 |
| 111 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.20002945 |
| 112 | negative regulation of sister chromatid segregation (GO:0033046) | 3.20002945 |
| 113 | mitotic spindle checkpoint (GO:0071174) | 3.19000031 |
| 114 | rRNA methylation (GO:0031167) | 3.17355073 |
| 115 | chromatin remodeling at centromere (GO:0031055) | 3.15741610 |
| 116 | protein localization to kinetochore (GO:0034501) | 3.15325039 |
| 117 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.15015830 |
| 118 | kinetochore assembly (GO:0051382) | 3.14834214 |
| 119 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.13961634 |
| 120 | * cell cycle G1/S phase transition (GO:0044843) | 3.13961634 |
| 121 | formation of translation preinitiation complex (GO:0001731) | 3.13526957 |
| 122 | nucleobase biosynthetic process (GO:0046112) | 3.13467815 |
| 123 | negative regulation of chromosome segregation (GO:0051985) | 3.13172575 |
| 124 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.12868349 |
| 125 | spliceosomal complex assembly (GO:0000245) | 3.12710897 |
| 126 | mitotic recombination (GO:0006312) | 3.12661487 |
| 127 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.12535130 |
| 128 | UTP biosynthetic process (GO:0006228) | 3.12412941 |
| 129 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.11783440 |
| 130 | termination of RNA polymerase I transcription (GO:0006363) | 3.10736238 |
| 131 | translational elongation (GO:0006414) | 3.10487241 |
| 132 | telomere maintenance via recombination (GO:0000722) | 3.08214007 |
| 133 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.06436698 |
| 134 | peptidyl-histidine modification (GO:0018202) | 3.05739345 |
| 135 | protein localization to mitochondrion (GO:0070585) | 3.05461077 |
| 136 | replication fork processing (GO:0031297) | 3.03836046 |
| 137 | IMP metabolic process (GO:0046040) | 3.03571962 |
| 138 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.03552069 |
| 139 | * positive regulation of cell cycle arrest (GO:0071158) | 3.01757755 |
| 140 | maturation of 5.8S rRNA (GO:0000460) | 3.01109820 |
| 141 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.00337030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.03131707 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.64881281 |
| 3 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.32328549 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.00880968 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.91164031 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.69445661 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.67864923 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.52380786 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.50648200 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.49130566 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.35473433 |
| 12 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.27294871 |
| 13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.05110621 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.01804433 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.98703831 |
| 16 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.98018251 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.90135544 |
| 18 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84391956 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.73197617 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.63215899 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.59246686 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.57276619 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.44052266 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.40018945 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.34728180 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.33850007 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.32883768 |
| 28 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.26940632 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.26708640 |
| 30 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.24432399 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.17378607 |
| 32 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.11486407 |
| 33 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.05761155 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.02373028 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.98267575 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.93795080 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.92933869 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.92293201 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86996576 |
| 40 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.82375741 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82252908 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.77496032 |
| 43 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.74582449 |
| 44 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74509256 |
| 45 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.67100322 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61398839 |
| 47 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59573738 |
| 48 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58836478 |
| 49 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.54626027 |
| 50 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.48719421 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.47599362 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45795363 |
| 53 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42712711 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40687297 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38570406 |
| 56 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.37059731 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.37031025 |
| 58 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.35605738 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34926041 |
| 60 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25517245 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25200663 |
| 62 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.23690181 |
| 63 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18874905 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17877772 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15886633 |
| 66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07820916 |
| 67 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05982121 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05375794 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03806056 |
| 70 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01749585 |
| 71 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97630532 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96982707 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96532588 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.96276662 |
| 75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95633078 |
| 76 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.94064169 |
| 77 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93904300 |
| 78 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92455606 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90448772 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90313629 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90295591 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89726688 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88982014 |
| 84 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88763257 |
| 85 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87448130 |
| 86 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86997055 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86787262 |
| 88 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.85336065 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84702242 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83725566 |
| 91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.83129117 |
| 92 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.82854720 |
| 93 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.82315442 |
| 94 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.82108765 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81044167 |
| 96 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.80418532 |
| 97 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.79805739 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79627697 |
| 99 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78636950 |
| 100 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78132044 |
| 101 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.77157933 |
| 102 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.76267536 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.75227244 |
| 104 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73223080 |
| 105 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.73035790 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72665359 |
| 107 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.72287096 |
| 108 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.71852062 |
| 109 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71529658 |
| 110 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.70902976 |
| 111 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.70651248 |
| 112 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.69873992 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.68746852 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66727223 |
| 115 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.66219428 |
| 116 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.66041507 |
| 117 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.65604849 |
| 118 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.64692042 |
| 119 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.64231021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.59789924 |
| 2 | MP0001529_abnormal_vocalization | 3.17227064 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.07015948 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 2.84121963 |
| 5 | MP0008058_abnormal_DNA_repair | 2.81004617 |
| 6 | MP0003880_abnormal_central_pattern | 2.76959227 |
| 7 | MP0001188_hyperpigmentation | 2.69551042 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.53967699 |
| 9 | MP0008057_abnormal_DNA_replication | 2.52087700 |
| 10 | MP0006292_abnormal_olfactory_placode | 2.43745862 |
| 11 | MP0001905_abnormal_dopamine_level | 2.41927692 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.29739203 |
| 13 | MP0003186_abnormal_redox_activity | 2.14500993 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.11171795 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.07279590 |
| 16 | MP0003890_abnormal_embryonic-extraembry | 2.07117615 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.07106938 |
| 18 | MP0000372_irregular_coat_pigmentation | 2.06143991 |
| 19 | MP0003786_premature_aging | 2.03440722 |
| 20 | MP0002163_abnormal_gland_morphology | 1.99435474 |
| 21 | MP0003136_yellow_coat_color | 1.98654305 |
| 22 | MP0003077_abnormal_cell_cycle | 1.96828970 |
| 23 | MP0003718_maternal_effect | 1.93572760 |
| 24 | MP0000566_synostosis | 1.85537913 |
| 25 | MP0009697_abnormal_copulation | 1.84857510 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.83856527 |
| 27 | MP0002254_reproductive_system_inflammat | 1.82473683 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.81990722 |
| 29 | MP0002938_white_spotting | 1.81095006 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.79904198 |
| 31 | MP0001293_anophthalmia | 1.76592596 |
| 32 | MP0004147_increased_porphyrin_level | 1.70794857 |
| 33 | MP0002102_abnormal_ear_morphology | 1.68888328 |
| 34 | MP0002132_abnormal_respiratory_system | 1.64649811 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.61978791 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.60895981 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.60444585 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.57049165 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.56794207 |
| 40 | MP0003123_paternal_imprinting | 1.55243874 |
| 41 | MP0003724_increased_susceptibility_to | 1.52187080 |
| 42 | MP0003195_calcinosis | 1.46475500 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.45961721 |
| 44 | MP0002751_abnormal_autonomic_nervous | 1.45408931 |
| 45 | MP0005171_absent_coat_pigmentation | 1.43313700 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.41986025 |
| 47 | MP0002160_abnormal_reproductive_system | 1.41434272 |
| 48 | MP0001730_embryonic_growth_arrest | 1.39310236 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.37099049 |
| 50 | MP0003567_abnormal_fetal_cardiomyocyte | 1.36428910 |
| 51 | MP0002736_abnormal_nociception_after | 1.30366532 |
| 52 | MP0002095_abnormal_skin_pigmentation | 1.26910552 |
| 53 | MP0001764_abnormal_homeostasis | 1.25644585 |
| 54 | MP0001697_abnormal_embryo_size | 1.23184075 |
| 55 | MP0008995_early_reproductive_senescence | 1.22120686 |
| 56 | MP0003941_abnormal_skin_development | 1.20519911 |
| 57 | MP0003315_abnormal_perineum_morphology | 1.20308771 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.19559761 |
| 59 | MP0004142_abnormal_muscle_tone | 1.18491896 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.16631278 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.15847132 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.15507082 |
| 63 | MP0001542_abnormal_bone_strength | 1.15362591 |
| 64 | MP0009785_altered_susceptibility_to | 1.14102923 |
| 65 | MP0010307_abnormal_tumor_latency | 1.11504471 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.11013272 |
| 67 | MP0003937_abnormal_limbs/digits/tail_de | 1.10930088 |
| 68 | MP0003121_genomic_imprinting | 1.10014184 |
| 69 | MP0002090_abnormal_vision | 1.08868131 |
| 70 | MP0005408_hypopigmentation | 1.08595834 |
| 71 | MP0001672_abnormal_embryogenesis/_devel | 1.07491256 |
| 72 | MP0005380_embryogenesis_phenotype | 1.07491256 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.07413619 |
| 74 | MP0000647_abnormal_sebaceous_gland | 1.05792007 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.05465731 |
| 76 | MP0001929_abnormal_gametogenesis | 1.04851114 |
| 77 | MP0003122_maternal_imprinting | 1.03543119 |
| 78 | MP0004381_abnormal_hair_follicle | 1.03272571 |
| 79 | MP0005389_reproductive_system_phenotype | 1.02134539 |
| 80 | MP0005409_darkened_coat_color | 1.01724973 |
| 81 | MP0000049_abnormal_middle_ear | 0.99683732 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 0.97558884 |
| 83 | MP0001968_abnormal_touch/_nociception | 0.97518667 |
| 84 | MP0005253_abnormal_eye_physiology | 0.97365983 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.96536785 |
| 86 | MP0010030_abnormal_orbit_morphology | 0.95988125 |
| 87 | MP0006054_spinal_hemorrhage | 0.95766489 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95223467 |
| 89 | MP0005395_other_phenotype | 0.94400826 |
| 90 | MP0002085_abnormal_embryonic_tissue | 0.93803990 |
| 91 | MP0002080_prenatal_lethality | 0.92685868 |
| 92 | MP0002084_abnormal_developmental_patter | 0.91158710 |
| 93 | MP0003011_delayed_dark_adaptation | 0.91020621 |
| 94 | MP0000653_abnormal_sex_gland | 0.90182918 |
| 95 | MP0005394_taste/olfaction_phenotype | 0.89532266 |
| 96 | MP0005499_abnormal_olfactory_system | 0.89532266 |
| 97 | MP0001145_abnormal_male_reproductive | 0.89182430 |
| 98 | MP0008872_abnormal_physiological_respon | 0.88225158 |
| 99 | MP0001119_abnormal_female_reproductive | 0.86915284 |
| 100 | MP0009672_abnormal_birth_weight | 0.85519286 |
| 101 | MP0000681_abnormal_thyroid_gland | 0.84638485 |
| 102 | MP0002233_abnormal_nose_morphology | 0.84061122 |
| 103 | MP0001984_abnormal_olfaction | 0.83579343 |
| 104 | MP0003119_abnormal_digestive_system | 0.83051953 |
| 105 | MP0000631_abnormal_neuroendocrine_gland | 0.82941858 |
| 106 | MP0010352_gastrointestinal_tract_polyps | 0.82058228 |
| 107 | MP0008260_abnormal_autophagy | 0.81647340 |
| 108 | MP0001835_abnormal_antigen_presentation | 0.80878339 |
| 109 | MP0002088_abnormal_embryonic_growth/wei | 0.79840209 |
| 110 | MP0003984_embryonic_growth_retardation | 0.79672511 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.79534367 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.77802225 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.76883199 |
| 114 | MP0000026_abnormal_inner_ear | 0.76053714 |
| 115 | MP0000358_abnormal_cell_content/ | 0.75036807 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.74351527 |
| 117 | MP0002210_abnormal_sex_determination | 0.74286038 |
| 118 | MP0001919_abnormal_reproductive_system | 0.73927406 |
| 119 | MP0001286_abnormal_eye_development | 0.73908258 |
| 120 | MP0005671_abnormal_response_to | 0.72607212 |
| 121 | MP0001881_abnormal_mammary_gland | 0.72379148 |
| 122 | MP0001853_heart_inflammation | 0.72311236 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70850560 |
| 124 | MP0004133_heterotaxia | 0.70656748 |
| 125 | MP0003938_abnormal_ear_development | 0.69857646 |
| 126 | MP0003787_abnormal_imprinting | 0.69597001 |
| 127 | MP0005332_abnormal_amino_acid | 0.69046396 |
| 128 | MP0005646_abnormal_pituitary_gland | 0.68750051 |
| 129 | MP0005645_abnormal_hypothalamus_physiol | 0.67341166 |
| 130 | MP0005174_abnormal_tail_pigmentation | 0.67254343 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.67066285 |
| 132 | MP0002111_abnormal_tail_morphology | 0.66662499 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.66526682 |
| 134 | MP0005367_renal/urinary_system_phenotyp | 0.65220505 |
| 135 | MP0000516_abnormal_urinary_system | 0.65220505 |
| 136 | MP0000313_abnormal_cell_death | 0.64679637 |
| 137 | MP0008873_increased_physiological_sensi | 0.64404679 |
| 138 | MP0002272_abnormal_nervous_system | 0.63179744 |
| 139 | MP0002734_abnormal_mechanical_nocicepti | 0.63173995 |
| 140 | MP0000490_abnormal_crypts_of | 0.63065290 |
| 141 | MP0000350_abnormal_cell_proliferation | 0.62534370 |
| 142 | MP0003656_abnormal_erythrocyte_physiolo | 0.60686628 |
| 143 | MP0005551_abnormal_eye_electrophysiolog | 0.60014272 |
| 144 | MP0001186_pigmentation_phenotype | 0.59574964 |
| 145 | MP0005423_abnormal_somatic_nervous | 0.57849419 |
| 146 | MP0001963_abnormal_hearing_physiology | 0.56771783 |
| 147 | MP0004924_abnormal_behavior | 0.55323810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.60512988 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.06945323 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.04010765 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.56929596 |
| 5 | Increased CSF lactate (HP:0002490) | 4.45947224 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.41802624 |
| 7 | Acute encephalopathy (HP:0006846) | 4.36015287 |
| 8 | 3-Methylglutaconic aciduria (HP:0003535) | 4.16396656 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.05199231 |
| 10 | Hepatic necrosis (HP:0002605) | 3.81594757 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.70298538 |
| 12 | Abnormality of glycolysis (HP:0004366) | 3.70298538 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.64120651 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.64120651 |
| 15 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.58334626 |
| 16 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.56220533 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.48442828 |
| 18 | Increased serum lactate (HP:0002151) | 3.44304001 |
| 19 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.42948351 |
| 20 | Renal Fanconi syndrome (HP:0001994) | 3.41955779 |
| 21 | Abnormal number of erythroid precursors (HP:0012131) | 3.35448544 |
| 22 | Exercise intolerance (HP:0003546) | 3.24415618 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 3.18786742 |
| 24 | Abnormality of the labia minora (HP:0012880) | 3.11354857 |
| 25 | Colon cancer (HP:0003003) | 3.04785385 |
| 26 | Birth length less than 3rd percentile (HP:0003561) | 3.00479116 |
| 27 | Lactic acidosis (HP:0003128) | 2.97179255 |
| 28 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.93491705 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 2.93471924 |
| 30 | Meckel diverticulum (HP:0002245) | 2.90866338 |
| 31 | Reticulocytopenia (HP:0001896) | 2.88241363 |
| 32 | Respiratory failure (HP:0002878) | 2.87548750 |
| 33 | Optic disc pallor (HP:0000543) | 2.87340699 |
| 34 | Methylmalonic acidemia (HP:0002912) | 2.85099823 |
| 35 | Chromsome breakage (HP:0040012) | 2.83586285 |
| 36 | Increased intramyocellular lipid droplets (HP:0012240) | 2.83105959 |
| 37 | Exertional dyspnea (HP:0002875) | 2.82639401 |
| 38 | Abnormality of chromosome stability (HP:0003220) | 2.81003459 |
| 39 | Cerebral edema (HP:0002181) | 2.79212402 |
| 40 | Abnormality of the ileum (HP:0001549) | 2.76375165 |
| 41 | Hypothermia (HP:0002045) | 2.67384527 |
| 42 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.65693003 |
| 43 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.64257428 |
| 44 | Leukodystrophy (HP:0002415) | 2.60929909 |
| 45 | Aplastic anemia (HP:0001915) | 2.60832374 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60224160 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.56893050 |
| 48 | Respiratory difficulties (HP:0002880) | 2.56889317 |
| 49 | Cerebral hypomyelination (HP:0006808) | 2.52935731 |
| 50 | Irregular epiphyses (HP:0010582) | 2.52012445 |
| 51 | Methylmalonic aciduria (HP:0012120) | 2.47434446 |
| 52 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.45057522 |
| 53 | Abnormality of alanine metabolism (HP:0010916) | 2.45057522 |
| 54 | Hyperalaninemia (HP:0003348) | 2.45057522 |
| 55 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44063594 |
| 56 | Macrocytic anemia (HP:0001972) | 2.41079758 |
| 57 | Microvesicular hepatic steatosis (HP:0001414) | 2.39660125 |
| 58 | Hyperglycinemia (HP:0002154) | 2.39245504 |
| 59 | Parakeratosis (HP:0001036) | 2.35922967 |
| 60 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.33095951 |
| 61 | Multiple enchondromatosis (HP:0005701) | 2.32421283 |
| 62 | Breast hypoplasia (HP:0003187) | 2.30316618 |
| 63 | Lethargy (HP:0001254) | 2.29823277 |
| 64 | Pallor (HP:0000980) | 2.27347317 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 2.26061897 |
| 66 | Type 2 muscle fiber atrophy (HP:0003554) | 2.23334021 |
| 67 | Degeneration of anterior horn cells (HP:0002398) | 2.22586179 |
| 68 | Abnormality of the anterior horn cell (HP:0006802) | 2.22586179 |
| 69 | Reduced antithrombin III activity (HP:0001976) | 2.22533937 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.22229912 |
| 71 | Megaloblastic anemia (HP:0001889) | 2.21970750 |
| 72 | Oral leukoplakia (HP:0002745) | 2.21964980 |
| 73 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21430798 |
| 74 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21430798 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.21430798 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.21430798 |
| 77 | Duodenal stenosis (HP:0100867) | 2.21041674 |
| 78 | Small intestinal stenosis (HP:0012848) | 2.21041674 |
| 79 | True hermaphroditism (HP:0010459) | 2.20138575 |
| 80 | Increased muscle lipid content (HP:0009058) | 2.17583855 |
| 81 | Rough bone trabeculation (HP:0100670) | 2.17096978 |
| 82 | Abnormality of renal resorption (HP:0011038) | 2.14561079 |
| 83 | Neoplasm of the adrenal gland (HP:0100631) | 2.11945169 |
| 84 | Nephrogenic diabetes insipidus (HP:0009806) | 2.10393478 |
| 85 | Congenital primary aphakia (HP:0007707) | 2.05944132 |
| 86 | Abnormality of the duodenum (HP:0002246) | 2.01268088 |
| 87 | Pancreatic cysts (HP:0001737) | 1.99240152 |
| 88 | Gait imbalance (HP:0002141) | 1.98408571 |
| 89 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.95495556 |
| 90 | Abnormality of glycine metabolism (HP:0010895) | 1.95078912 |
| 91 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95078912 |
| 92 | CNS demyelination (HP:0007305) | 1.93045837 |
| 93 | Abnormal hair whorl (HP:0010721) | 1.92201238 |
| 94 | Bifid tongue (HP:0010297) | 1.90503666 |
| 95 | Rhabdomyosarcoma (HP:0002859) | 1.89742676 |
| 96 | Ependymoma (HP:0002888) | 1.89081056 |
| 97 | Horseshoe kidney (HP:0000085) | 1.87454138 |
| 98 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.87264772 |
| 99 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.87203797 |
| 100 | Hyperglycinuria (HP:0003108) | 1.87175850 |
| 101 | Abnormality of the pons (HP:0007361) | 1.86818240 |
| 102 | Muscle fiber atrophy (HP:0100295) | 1.86120558 |
| 103 | Sloping forehead (HP:0000340) | 1.85914387 |
| 104 | Hypoplastic pelvis (HP:0008839) | 1.84868824 |
| 105 | Congenital, generalized hypertrichosis (HP:0004540) | 1.84045702 |
| 106 | Molar tooth sign on MRI (HP:0002419) | 1.82732333 |
| 107 | Abnormality of midbrain morphology (HP:0002418) | 1.82732333 |
| 108 | Triphalangeal thumb (HP:0001199) | 1.81009211 |
| 109 | Premature graying of hair (HP:0002216) | 1.80773816 |
| 110 | Pancytopenia (HP:0001876) | 1.79774822 |
| 111 | Amniotic constriction ring (HP:0009775) | 1.79741306 |
| 112 | Abnormality of placental membranes (HP:0011409) | 1.79741306 |
| 113 | Median cleft lip (HP:0000161) | 1.78805702 |
| 114 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.78556349 |
| 115 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78314377 |
| 116 | Severe visual impairment (HP:0001141) | 1.78234304 |
| 117 | Hypoplasia of the pons (HP:0012110) | 1.77283207 |
| 118 | Abnormal trabecular bone morphology (HP:0100671) | 1.76885573 |
| 119 | Volvulus (HP:0002580) | 1.76522885 |
| 120 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.75944590 |
| 121 | Abnormal lung lobation (HP:0002101) | 1.75438397 |
| 122 | Myelodysplasia (HP:0002863) | 1.74815921 |
| 123 | Absent epiphyses (HP:0010577) | 1.73622883 |
| 124 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.73622883 |
| 125 | X-linked dominant inheritance (HP:0001423) | 1.72464613 |
| 126 | Poor head control (HP:0002421) | 1.67774984 |
| 127 | Sparse eyelashes (HP:0000653) | 1.67553885 |
| 128 | Emotional lability (HP:0000712) | 1.67247967 |
| 129 | Carpal bone hypoplasia (HP:0001498) | 1.66598836 |
| 130 | Cleft eyelid (HP:0000625) | 1.64777733 |
| 131 | Adrenal hypoplasia (HP:0000835) | 1.63676755 |
| 132 | Patchy hypopigmentation of hair (HP:0011365) | 1.63326171 |
| 133 | Poor suck (HP:0002033) | 1.63296467 |
| 134 | Abnormal pupillary function (HP:0007686) | 1.61746145 |
| 135 | Abnormality of the axillary hair (HP:0100134) | 1.61268958 |
| 136 | Abnormality of secondary sexual hair (HP:0009888) | 1.61268958 |
| 137 | Postnatal microcephaly (HP:0005484) | 1.60939316 |
| 138 | Abnormality of urine glucose concentration (HP:0011016) | 1.59322671 |
| 139 | Glycosuria (HP:0003076) | 1.59322671 |
| 140 | Abnormality of the preputium (HP:0100587) | 1.58881370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.15961401 |
| 2 | VRK2 | 3.54385842 |
| 3 | BUB1 | 3.40676646 |
| 4 | EIF2AK1 | 3.21852405 |
| 5 | CASK | 2.69719776 |
| 6 | NEK1 | 2.65493978 |
| 7 | EIF2AK3 | 2.61068811 |
| 8 | NME2 | 2.59011894 |
| 9 | TRIM28 | 2.50893489 |
| 10 | SRPK1 | 2.49688005 |
| 11 | WEE1 | 2.39741262 |
| 12 | NME1 | 2.37499833 |
| 13 | PBK | 2.32514366 |
| 14 | VRK1 | 2.28325212 |
| 15 | MKNK1 | 2.22249604 |
| 16 | TNIK | 2.14476304 |
| 17 | NUAK1 | 2.05617908 |
| 18 | MAP3K12 | 1.91771513 |
| 19 | PIM2 | 1.77768221 |
| 20 | MST4 | 1.76769434 |
| 21 | ACVR1B | 1.76723877 |
| 22 | PLK4 | 1.76352165 |
| 23 | BMPR1B | 1.75813292 |
| 24 | TAF1 | 1.73187624 |
| 25 | MKNK2 | 1.72669780 |
| 26 | TSSK6 | 1.70486087 |
| 27 | BCR | 1.59354417 |
| 28 | MAP4K2 | 1.58393994 |
| 29 | CDK8 | 1.40180159 |
| 30 | BRSK2 | 1.39707750 |
| 31 | AKT3 | 1.35998176 |
| 32 | EIF2AK2 | 1.34804310 |
| 33 | MAP2K7 | 1.31630391 |
| 34 | CCNB1 | 1.31494072 |
| 35 | ZAK | 1.26959278 |
| 36 | PLK3 | 1.23883107 |
| 37 | PLK2 | 1.23525888 |
| 38 | BMPR2 | 1.23443416 |
| 39 | ERBB3 | 1.22865782 |
| 40 | CDC7 | 1.19856704 |
| 41 | BRAF | 1.19705998 |
| 42 | TLK1 | 1.16719079 |
| 43 | ARAF | 1.16440542 |
| 44 | CDK19 | 1.16378515 |
| 45 | PDK2 | 1.16255174 |
| 46 | LIMK1 | 1.15022047 |
| 47 | DYRK2 | 1.12778001 |
| 48 | ADRBK2 | 1.07938364 |
| 49 | SIK3 | 0.98876876 |
| 50 | YES1 | 0.97901246 |
| 51 | CSNK1G1 | 0.97456060 |
| 52 | AURKA | 0.92528042 |
| 53 | MYLK | 0.92101648 |
| 54 | IRAK4 | 0.90751792 |
| 55 | GRK7 | 0.86715483 |
| 56 | TESK2 | 0.86079200 |
| 57 | FRK | 0.86038560 |
| 58 | MAPK13 | 0.84601145 |
| 59 | MUSK | 0.82264259 |
| 60 | DYRK3 | 0.80695161 |
| 61 | GRK1 | 0.80627861 |
| 62 | PLK1 | 0.79916854 |
| 63 | TXK | 0.78466443 |
| 64 | CSNK1G2 | 0.76542918 |
| 65 | STK4 | 0.76466766 |
| 66 | OBSCN | 0.76002561 |
| 67 | CSNK1A1L | 0.72009953 |
| 68 | PAK4 | 0.71375652 |
| 69 | TGFBR1 | 0.69405523 |
| 70 | OXSR1 | 0.68634810 |
| 71 | ABL2 | 0.65846152 |
| 72 | * CSNK2A1 | 0.65171310 |
| 73 | MAP3K4 | 0.65093218 |
| 74 | ERBB4 | 0.63759872 |
| 75 | STK3 | 0.63274891 |
| 76 | TESK1 | 0.62235252 |
| 77 | NEK6 | 0.61806977 |
| 78 | AURKB | 0.61634677 |
| 79 | TEC | 0.60461178 |
| 80 | ATM | 0.57962147 |
| 81 | RPS6KA4 | 0.56832169 |
| 82 | PASK | 0.56214992 |
| 83 | STK24 | 0.56151766 |
| 84 | PNCK | 0.55957893 |
| 85 | KDR | 0.55115608 |
| 86 | IRAK3 | 0.54860517 |
| 87 | BRSK1 | 0.54525720 |
| 88 | CSNK1G3 | 0.52852636 |
| 89 | * CSNK2A2 | 0.52191195 |
| 90 | STK10 | 0.51985414 |
| 91 | DAPK1 | 0.50678664 |
| 92 | CHEK1 | 0.50534150 |
| 93 | ADRBK1 | 0.49968413 |
| 94 | CDK7 | 0.49703277 |
| 95 | ATR | 0.48381473 |
| 96 | MAPKAPK5 | 0.48373561 |
| 97 | NEK2 | 0.47201544 |
| 98 | CDK3 | 0.46455098 |
| 99 | PRPF4B | 0.46298349 |
| 100 | RPS6KA5 | 0.45463221 |
| 101 | ALK | 0.44405963 |
| 102 | STK38L | 0.40753045 |
| 103 | MAP3K14 | 0.40162552 |
| 104 | INSRR | 0.37424741 |
| 105 | FGFR1 | 0.37337220 |
| 106 | RPS6KB2 | 0.37222905 |
| 107 | CHEK2 | 0.37102108 |
| 108 | MARK1 | 0.36906017 |
| 109 | IRAK1 | 0.35390357 |
| 110 | CAMK2B | 0.35338458 |
| 111 | CSNK1E | 0.34979484 |
| 112 | BCKDK | 0.34661077 |
| 113 | LYN | 0.33261938 |
| 114 | STK39 | 0.33188166 |
| 115 | MAP3K8 | 0.32096298 |
| 116 | GRK5 | 0.31790640 |
| 117 | WNK3 | 0.30309676 |
| 118 | PRKCI | 0.29242128 |
| 119 | CAMKK2 | 0.29216824 |
| 120 | TTK | 0.28097467 |
| 121 | PINK1 | 0.27996480 |
| 122 | PRKCE | 0.27787343 |
| 123 | PRKCG | 0.26723051 |
| 124 | EPHA2 | 0.26703853 |
| 125 | NLK | 0.26692282 |
| 126 | CDK1 | 0.26435891 |
| 127 | CLK1 | 0.26176172 |
| 128 | PAK1 | 0.25851357 |
| 129 | FLT3 | 0.23808360 |
| 130 | IKBKB | 0.23669123 |
| 131 | CSNK1A1 | 0.23567140 |
| 132 | SCYL2 | 0.23519486 |
| 133 | CDK9 | 0.22489248 |
| 134 | MINK1 | 0.20172343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Proteasome_Homo sapiens_hsa03050 | 5.12054017 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.05622058 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.87583454 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.68578909 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.33310624 |
| 6 | Protein export_Homo sapiens_hsa03060 | 3.30177100 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 3.01667875 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.61506195 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.58605750 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.53642911 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.43610554 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.34677488 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.31879816 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.25992010 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.22111284 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.88732572 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.84424895 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.83648412 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.74620175 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74564791 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74285888 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.69146636 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.61046312 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49180466 |
| 25 | Purine metabolism_Homo sapiens_hsa00230 | 1.48249657 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.44870554 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.42210401 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39435796 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38808351 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35714250 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30458473 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25238181 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19840598 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17150686 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15839142 |
| 36 | Cell cycle_Homo sapiens_hsa04110 | 1.14382803 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06767044 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02638037 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99631224 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93070201 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91047220 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90309612 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87075723 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85943310 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82701751 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80482715 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78632195 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.78112352 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77617891 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77045902 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76352983 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75939395 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75732713 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71478265 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70374390 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70033554 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68174986 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65701678 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64517911 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63764480 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61897321 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.59804145 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.59519145 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59425315 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55123966 |
| 66 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.55030429 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54925523 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53763388 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.52811879 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52415386 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52266738 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50617832 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.50543030 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.49971237 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49174355 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48878544 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47218208 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45584628 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45249640 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45106154 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44700089 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43057136 |
| 83 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42744688 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42731063 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42235844 |
| 86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40394944 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40257118 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39694084 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39507328 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37773176 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37436135 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37035442 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34781713 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34603921 |
| 95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34227506 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33875346 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31630069 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.29429920 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29353755 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29196542 |
| 101 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29048257 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27848901 |
| 103 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.27725304 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.27273443 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26695395 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26521953 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24505425 |
| 108 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.22827669 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.22605605 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.22394380 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22345219 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22040878 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21239115 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21106202 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.20952313 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20637800 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20542576 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.19742310 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18842034 |
| 120 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.18590078 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.18303009 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17717616 |
| 123 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.17425093 |
| 124 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.17189347 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.16891400 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.16484493 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.16308134 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.15215170 |
| 129 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14168532 |
| 130 | Carbon metabolism_Homo sapiens_hsa01200 | 0.13359048 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.12319280 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.12123880 |
| 133 | Measles_Homo sapiens_hsa05162 | 0.10434926 |
| 134 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07926822 |

